Cagrilintide+Samaglutide,combination for weight management and glucose control

  • Purchase Qty: 1
  • Unit: Vial(s)
  • Fob Unit Price: US $1
  • Production Capacity:1, 000, 000 Vials/month
  • Payment Terms:L/C , T/T , PayPal , Small-amount payment , Money Gram , EXW
  • Favorite
Shandong Sino Pharmaceutical Technology Co., Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

6/10

Product Information

  • Specification:2.5mg+2.5mg/5mg+5mg/vial
  • Dosage Form:Injection
  • Active Ingredients:Cagrilintide+Samaglutide
  • Route of Administration:Subcutaneous Injection
  • Shelf Life:2 years
  • Storage:Protected from light
  • Package:10vials/box
  • Place of Origin:china
  • Qualification:Chinese GMP

Description

We are supplying all of our  foreign customers with Customized Pharmaceutical Formulations or Dosage Forms.

 

You can tell us any pharmaceutical product, no matter what it is that you want. And then we will give you a detailed solution as per your requirement.  

There are two specifications:2.5mg+2.5mg/vial(total 5mg) 

                                              5mg+5mg/vial(total 10mg)


  1. Cagrilintide

    Type: Synthetic peptide.

    Use: Cagrilintide is an experimental peptide that acts as an amylin analogue, mimicking the effects of the natural hormone amylin.   It has been researched for its potential in weight loss and diabetes treatment.   It can work synergistically with other treatments like GLP-1 agonists to enhance satiety and reduce hunger.

    Mechanism: As an amylin analogue, it helps to regulate glucose metabolism, slow gastric emptying, and reduce appetite, which can help with weight management.

    2.Semaglutide

         Type: GLP-1 receptor agonist.

         Use: Semaglutide is widely used for treating type 2 diabetes and obesity.   It is marketed under names like Ozempic (for diabetes) and Wegovy (for weight loss).

         Mechanism: It mimics the action of GLP-1 (glucagon-like peptide-1), which stimulates insulin secretion in response to meals, reduces glucagon secretion, and slows gastric emptying, helping to control blood sugar levels and reduce appetite.

      

      3.Combination (Cagrilintide + Semaglutide)

      The combination of Cagrilintide and Semaglutide could potentially offer enhanced benefits for weight management and glucose control, due to their complementary effects:Semaglutide helps regulate glucose and reduces appetite.Cagrilintide further reduces appetite and enhances satiety, potentially making weight loss more effective.




You Might Also Like
Change a group
Inquiry Cart(0)